Berenberg Bank Reiterates €81.00 Price Target for Gerresheimer (ETR:GXI)

Gerresheimer (ETR:GXI) has been assigned a €81.00 ($94.19) price objective by research analysts at Berenberg Bank in a research report issued to clients and investors on Thursday, Borsen Zeitung reports. The brokerage currently has a “buy” rating on the stock. Berenberg Bank’s price objective would indicate a potential upside of 25.87% from the stock’s current price.

A number of other brokerages have also recently issued reports on GXI. JPMorgan Chase & Co. set a €56.40 ($65.58) target price on Gerresheimer and gave the stock a “sell” rating in a report on Monday, October 7th. Deutsche Bank set a €83.00 ($96.51) target price on Gerresheimer and gave the stock a “buy” rating in a report on Monday, October 7th. Hauck & Aufhaeuser set a €50.00 ($58.14) price target on Gerresheimer and gave the company a “sell” rating in a research note on Friday, July 12th. Goldman Sachs Group set a €65.00 ($75.58) price target on Gerresheimer and gave the company a “neutral” rating in a research note on Thursday. Finally, DZ Bank reissued a “neutral” rating on shares of Gerresheimer in a research note on Thursday, July 11th. Three investment analysts have rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of €72.16 ($83.90).

Shares of GXI opened at €64.35 ($74.83) on Thursday. Gerresheimer has a 12-month low of €51.10 ($59.42) and a 12-month high of €74.80 ($86.98). The business has a 50-day simple moving average of €66.93 and a two-hundred day simple moving average of €67.48. The company has a quick ratio of 0.56, a current ratio of 0.85 and a debt-to-equity ratio of 64.56. The stock has a market cap of $2.02 billion and a PE ratio of 9.76.

About Gerresheimer

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Featured Story: What does a bar chart mean for investors?

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit